Genomics in Cancer Care Market is valued at USD 12210.1 Million in 2018 and expected to reach USD 32976.7 Million by 2025 with a CAGR of 15.25% over the forecast period. Rising investments in biotech & pharmaceutical industry and increasing R&D activities for the development of novel treatment therapies are the major factors attributing towards the growth of Global Genomics in Cancer Care Market.
Scopeof Genomics in Cancer Care Market Report:
Scope of Global Genomics in Cancer Care Market Report– Advanced genomic testing is designed to help in recognizing the DNA variations which may cause the growth of a specific tumor. Information about genomic mutations that are unique to individual cancer may help doctors to identify treatments designed to target those mutations. Genomics is basically an investigation of grouping of letters in the DNA and how each string exchanges data to help cells in the body framework to work appropriately. In cancer, minor changes in these hereditary letters can change the importance of what a genomic word implies. An adjustment in single letter can move the cell to make a protein that won't enable the cell to work appropriately. The investigation of malignancy genome has uncovered numerous variations from the norm in qualities that has driven the development of numerous different kinds of diseases.
Global genomics in cancer care market report is segmented on the basis of product, application, technology and regional & country level. Based on product, global genomics in cancer care market is classified as instruments, consumables, and services. Based upon application, global genomics in cancer care market is classified into diagnostics, personalized medicines, drug discovery & development, and research. Based upon technology, global genomics in cancer care market is classified as genome sequencing, PCR, microarrays, nucleic acid extraction & purification, and others.
The regions covered in this Genomics in Cancer Care Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Genomics in Cancer Care is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Genomics in Cancer Care Market Report- Global genomics in cancer care market report covers prominent players likeBeckman Coulter Inc., Illumina, Inc., Affymetrix, Roche Diagnostics, Agilent Technologies, Cancer Genetics Inc., Danaher Corporation, Bio-Rad Labs, Pacific Biosciences, Quest Diagnostics, Sigma Aldrich, Luminex, Thermo Fisher scientific, Oxford Gene Technology., PerkinElmer, Qiagen, GE Healthcare and others.
Global Genomics in Cancer Care Market Dynamics– Rising demand for personalized medicine for the molecular characterization of cancer, increased healthcare expenditure, rapid development in therapeutics and diagnostic procedures and high prevalence of cancer across the globe are some of the factors driving the growth of the market. According to World Health Organization, the global cancer burden has enhanced to 18.1 million new cases. The number of deaths due to cancer was 9.6 million in 2018. However, the low rate of adoption of genomics in cancer care in the developing economies and the high cost associated with it is estimated to restrain the growth of the market over the forecast period.
Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Genomics in Cancer Care Market.
Key Benefits for Genomics in Cancer Care Market Reports
• Global market report covers in-depth historical and forecast analysis.
• Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global market report helps to identify opportunities in market place.
• Global market report covers extensive analysis of emerging trends and competitive landscape.
Global Genomics in Cancer Care Market Segmentation:–
By Product Type:
• Instruments
• Consumables
• Services
By Application:
• Diagnostics
• Personalized medicine
• Drug discovery & development
• Research
By Technology:
• Genome sequencing
• PCR
• Microarrays
• Nucleic acid extraction & purification
• Other
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o France
o Germany
o Russia
o Rest of Europe
• Asia-Pacific
o China
o South Korea
o India
o Japan
o Rest of Asia-Pacific
• LAMEA
o Latin America
o Middle East
o Africa
North America is Expecetd to Dominate the Global Genomics in Cancer Care Market. North America holds a dominating position in the global genomics in cancer care market followed by Europe and Asia Pacific. The market growth in North America is driven by the presence of refined research & development infrastructure for the researchers, large pool of patients suffering from cancer and high healthcare expenditure by the individuals in this region. Whereas, Asia Pacific is expected to reach significant growth due to the increased penetration rate of these technologies and improving research and development expenditure by the biopharma industries in this region within the forecast period.
Genomics in Cancer Care Market Key Players:
• Illumina
• Thermo Fisher scientific
• Agilent
• Roche
• Cancer Genetics
• Beckman Coulter
• Bio-Rad
• Danaher
• Sigma Aldrich
• Pacific Biosciences
• Others
This comprehensive report will provide:
• Enhance your strategic decision making
• Assist with your research, presentations and business plans
• Show which emerging market opportunities to focus on
• Increase your industry knowledge
• Keep you up-to-date with crucial market developments
• Allow you to develop informed growth strategies
• Build your technical insight
• Illustrate trends to exploit
• Strengthen your analysis of competitors
• Provide risk analysis, helping you avoid the pitfalls other companies could make
• Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
• How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
• Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content
1. Chapter - Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Genomics in Cancer Care Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Genomics in Cancer Care Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Genomics in Cancer Care Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter - Global Genomics in Cancer Care Market Overview: Quantitative Analysis
3.1. Global Genomics in Cancer Care Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Genomics in Cancer Care Market Revenue Market Share (%), 2014- 2025
3.3. Global Genomics in Cancer Care Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Genomics in Cancer Care Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Genomics in Cancer Care Market Analysis: By Product
5. Chapter – Global Genomics in Cancer Care Market Analysis: By Technology
6. Chapter – Global Genomics in Cancer Care Market Analysis: By Application
7. Chapter – Global Genomics in Cancer Care Market Analysis: By End-Use
8. Chapter - Global Genomics in Cancer Care Market Analysis: By Manufacturer
8.1. Global Genomics in Cancer Care Market Revenue (USD Million), by Manufacturer, 2014 - 2025
8.2. Global Genomics in Cancer Care Market Share (%), by Manufacturer, 2018
8.3. Global Genomics in Cancer Care Market Sales (Number of Units), by Manufacturer, 2014 - 2025
8.4. Global Genomics in Cancer Care Market Share (%), by Manufacturer, 2018
8.5. Global Genomics in Cancer Care Market Price (USD/Unit), by Manufacturer, 2014 - 2025
8.6. Global Genomics in Cancer Care Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
8.7. Merger & Acquisition
8.8. Collaborations and Partnership
8.9. New Product Launch
9. Chapter –Genomics in Cancer Care Market: Regional Analysis
9.1. North America
9.1.1. North America Genomics in Cancer Care Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
9.1.2. North America Genomics in Cancer Care Market Revenue (USD Million) By Country, 2014 – 2025.
9.1.3. North America Genomics in Cancer Care Revenue Market Share (%) By Country, 2014 – 2025.
9.1.4. North America Genomics in Cancer Care Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
9.1.5. North America Genomics in Cancer Care Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
9.1.6. North America Genomics in Cancer Care Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
9.1.7. North America Genomics in Cancer Care Market Sales (Number of Units) By Country, 2014 – 2025.
9.1.8. North America Genomics in Cancer Care Sales Market Share (%) By Country, 2014 – 2025.
9.1.9. North America Genomics in Cancer Care Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
9.1.10. North America Genomics in Cancer Care Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
10. Chapter - Company Profiles
10.1. Illumina
10.1.1. Overview
10.1.2. Financials
10.1.3. Product portfolio
10.1.4. Genomics in Cancer Care Market Revenue (USD Million) and Market Share (%), 2014 - 2018
10.1.5. Genomics in Cancer Care Sales Market Share (%), 2014 - 2018
10.1.6. Business strategy
10.1.7. Recent developments
10.2. Thermo Fisher scientific
10.3. Agilent
10.4. Roche
10.5. Cancer Genetics
10.6. Beckman Coulter
10.7. Bio-Rad
10.8. Danaher
10.9. Sigma Aldrich
10.10. Pacific Biosciences
10.11. Quest Diagnostics
10.12. Luminex
10.13. Oxford Gene Technology
10.14. PerkinElmer
10.15. Qiagen
10.16. GE Healthcare
10.17. Thermo Fisher scientific
10.18. Others
11. Chapter – Market Research and Findings